跳至主要内容
临床试验/jRCT2031200143
jRCT2031200143已完成不适用

A long-term extension study of HP-5070 in patients with primary hyperhidrosis

Hisamitsu Pharmaceutical Co., Inc.0 个研究点目标入组 120 人开始时间: 2020年11月10日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
120
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study
干预模型
Single Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
12age old over 至 No limit(—)
性别
All

入选标准

  • Patients who continued into the extension
  • Japanese patients with primary local hyperhidrosis who completed the prior study
  • Patients wishing to continue to receive HP-5070 after participating in the prior study
  • New patients
  • Japanese patients aged 12 years or older
  • Patients with a diagnosis of primary local hyperhidrosis
  • Patients with involvement of palmar sites

排除标准

  • Patients who continued into the extension
  • Patients with a resting pulse rate of less than 45 beats per minute or more than 90 beats per minute measured during the pre-observation period of the prior study
  • Patients with a QTcF of 450 msec or more on a 12-lead ECG measured during the pre-observation period of the prior study
  • Patients with abnormal waveforms on a 12-lead ECG measured during the pre-observation period of the prior study
  • New patients
  • Patients with secondary hyperhidrosis
  • Patients with heavy sweating due to climacteric disturbance
  • Patients who have undergone surgery for hyperhidrosis (sympathectomy, nerve block, laser surgery, etc.)

结局指标

主要结局

-

Adverse events

次要结局

未报告次要终点

研究者

相似试验